TCRT icon

Alaunos Therapeutics

154 hedge funds and large institutions have $270M invested in Alaunos Therapeutics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 46 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 46

20% less capital invested

Capital invested by funds: $336M → $270M (-$66.8M)

Holders
154
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.98M
Puts
$2.32M
Net Calls
Net Calls Change

Top Buyers

1 +$3.47M
2 +$1.93M
3 +$1.91M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.89M
5
Bank of America
Bank of America
North Carolina
+$1.52M

Top Sellers

1 -$899K
2 -$590K
3 -$507K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$396K
5
UBS Group
UBS Group
Switzerland
-$273K
Name Holding Trade Value Shares
Change
Change in
Stake
76
$121K
77
$117K
78
$114K
79
$110K
80
$109K
81
$105K
82
$100K
83
$100K
84
$98K
85
$78K
86
$76K
87
$73K
88
$73K
89
$71K
90
$70K
91
$70K
92
$69K
93
$67K
94
$66K
95
$61K
96
$57K
97
$57K
98
$57K
99
$57K
100
$54K